Vasodilation, loop diuretics, or their combination in acute heart failure: Rationale and design of the randomized placebo-controlled DECONGEST-AHF trial
Anne Sophie Overgaard Olesen, Jasmin Dam Lukoschewitz, Ida Arentz Taraldsen, Ahmed Najim et autres
BACKGROUND: Acute heart failure is the leading cause of hospitalization in older adults and carries a high risk of short-term death or readmission. Initial treatment involves intravenous loop diuretics, often combined with vasodilators, despite limited evidence. The individual and combined effects of …
dk, gb (code pays fourni par la source)